Virtus Biotech Clinical Trials ETF (BBC)

Assets	$47.26M
Expense Ratio	0.65%
PE Ratio	n/a
Shares Out	n/a
Dividend (ttm)	$0.66
Dividend Yield	1.53%
Ex-Dividend Date	Dec 22, 2025
Payout Frequency	Annual
Payout Ratio	n/a

Volume	8,095
Open	43.59
Previous Close	44.08
Day's Range	42.21 - 43.59
52-Week Low	n/a
52-Week High	n/a
Beta	n/a
Holdings	123
Inception Date	Dec 16, 2014

About BBC

Fund Home Page

The Virtus Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBC
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Clinical Trials Index

Top 10 Holdings

16.26% of assets

Name	Symbol	Weight
Erasca, Inc.	ERAS	2.14%
Tango Therapeutics, Inc.	TNGX	1.86%
Enliven Therapeutics, Inc.	ELVN	1.86%
Spyre Therapeutics, Inc.	SYRE	1.65%
Oruka Therapeutics, Inc.	ORKA	1.59%
Alumis Inc.	ALMS	1.52%
Dianthus Therapeutics, Inc.	DNTH	1.51%
Corvus Pharmaceuticals, Inc.	CRVS	1.41%
Revolution Medicines, Inc.	RVMD	1.37%
Rezolute, Inc.	RZLT	1.36%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 22, 2025	$0.65544	Dec 29, 2025
Dec 20, 2024	$0.23947	Dec 27, 2024
Dec 20, 2023	$0.0823	Dec 29, 2023
Dec 20, 2017	$0.29724	Dec 27, 2017
Dec 21, 2015	$0.14733	Dec 29, 2015